Milestone Pharmaceuticals Inc (MIST): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 18.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5,857 US Dollar | 0 | 2 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 124.497.980 | 14,05 | 10,59 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Milestone Pharmaceuticals Inc
Mitarbeiter 38
Handelsplatz NASDAQ
Ticker Symbol MIST
IPO Datum 2019-05-09
Adresse 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
Webseite https://www.milestonepharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Joseph G. Oliveto M.B.A. | CEO, President & Executive Director |
| 2 | Mr. Amit Hasija | CFO & Executive VP of Corporate Development |
| 3 | Dr. David B. Bharucha FACC, M.D., Ph.D. | Chief Medical Officer |
| 4 | Dr. Philippe Douville M.B.A., Ph.D. | Founder, Strategic Advisor & Member of Scientific Advisory Board |
| 5 | Mr. Jeffrey Nelson | Chief Operating Officer |
| 6 | Mr. David Sandoval | General Counsel & Chief Compliance Officer |
| 7 | Mr. Roshan Girglani | Vice President of Marketing |
| 8 | Mr. Jeff Moore | Vice President of Sales |
| 9 | Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. | Chief Medical Advisor & Member of the Scientific Advisory Board |
| 10 | Dr. Guy Rousseau | SVP of Regulatory Affairs and Quality Management |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Propel Bio Management LLC | 5,97% | 6,83 Mio. USD |
| 2 | RTW INVESTMENTS, LLC | 5,09% | 5,82 Mio. USD |
| 3 | Simplify Asset Management Inc. | 2,69% | 3,08 Mio. USD |
| 4 | Millennium Management LLC | 2,52% | 2,89 Mio. USD |
| 5 | Two Sigma Investments LLC | 1,64% | 1,88 Mio. USD |
| 6 | The Goldman Sachs Group Inc | 1,61% | 1,84 Mio. USD |
| 7 | Marshall Wace Asset Management Ltd | 1,56% | 1,79 Mio. USD |
| 8 | Point72 Asset Management, L.P. | 0,87% | 1,00 Mio. USD |
| 9 | Balyasny Asset Management LLC | 0,68% | 0,78 Mio. USD |
| 10 | Lion Point Capital, LP | 0,66% | 0,75 Mio. USD |
| 11 | The Toronto-Dominion Bank | 0,60% | 0,69 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,58% | 0,67 Mio. USD |
| 13 | Boxer Capital Management, LLC | 0,54% | 0,61 Mio. USD |
| 14 | Susquehanna International Group, LLP | 0,42% | 0,48 Mio. USD |
| 15 | UBS Group AG | 0,40% | 0,46 Mio. USD |
| 16 | Squarepoint Ops LLC | 0,27% | 0,31 Mio. USD |
| 17 | Seven Fleet Capital Management LP | 0,27% | 0,31 Mio. USD |
| 18 | Aptus Capital Advisors, LLC | 0,23% | 0,26 Mio. USD |
| 19 | GUARDIAN WEALTH ADVISORS, LLC / NC | 0,23% | 0,26 Mio. USD |
| 20 | LPL Financial Corp | 0,16% | 0,18 Mio. USD |